Hopp til innhold
Close

Get alerts of updates about «Rheumatic fever»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Rheumatic fever

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Structured summary

Secondary prophylaxis with penicillin for rheumatic fever or established rheumatic heart disease

Published Updated

Prophylactic penicillin probably reduces rheumatic fever recurrences and streptococcal throat infections among children and adolescents with rheumatic fever or rheumatic heart disease (moderate certainty of evidence). The effect of prophylactic penicillin on mortality and adverse events among children and adolescents with rheumatic fever or rheumatic heart disease is uncertain (very low certainty of evidence).

Prophylactic penicillin probably reduces rheumatic fever recurrences and streptococcal throat infections among children and adolescents with rheumatic fever or rheumatic heart disease (moderate certainty of evidence). The effect of prophylactic penicillin on mortality and adverse events among children and adolescents with rheumatic fever or rheumatic heart disease is uncertain (very low certainty of evidence).


Order

DOWNLOAD

Secondary prophylaxis with penicillin for rheumatic fever or established rheumatic heart disease (pdf)

Plain language summary

Prophylactic penicillin probably reduces rheumatic fever recurrences and streptococcal throat infections among children and adolescents with rheumatic fever or rheumatic heart disease (moderate certainty of evidence).

The effect of prophylactic penicillin on mortality and adverse events among children and adolescents with rheumatic fever or rheumatic heart disease is uncertain (very low certainty of evidence).

No studies reported the effects on rheumatic heart disease progression and disability among children and adolescents with rheumatic fever or rheumatic heart disease.

Background

Acute rheumatic fever is an autoimmune disease that may occur following group A streptococcal throat infection. It can affect multiple systems, including the joints, heart, brain, and skin. Only the effects on the heart can lead to permanent illness; chronic changes to the heart valves are referred to as chronic rheumatic heart disease. No treatment has been shown to alter the progression of acute rheumatic fever to chronic rheumatic heart disease. Secondary prophylaxis can improve the prognosis of established rheumatic valvular disease. The recommended choice of treatment is long-term penicillin secondary prophylaxis (BMJ Best Practice (accessed Nov 20 2020)).

07.01.21: A few changes made in the method description part of the structured summary to make it more accessible.

This rapid review was commissioned by the Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen.

About this publication

  • Year: 2020
  • By: Norwegian Institute of Public Health (NIPH)
  • Authors Fønhus MS, Dalsbø TK.